| PATENT REGISTER | |||||||||||||||||||||
| A Supplementary Protection Certificate (SPC) exists for this Patent. To view the SPC Details click following SPC number(s): 2019/031 | |||||||||||||||||||||
| Status | Granted | Patent No. | 2300013 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Application No. | 09751617.3 | Date of Filing | 21/05/2009 | ||||||||||||||||||
| Date Grant Published | 06/09/2017 | Application Published | 30/03/2011 | ||||||||||||||||||
| Title of Invention | PHOSPHOROUS DERIVATIVES AS KINASE INHIBITORS | ||||||||||||||||||||
| Priority |
|
||||||||||||||||||||
| Inventors |
WANG, Yihan HUANG, Wei-Sheng LIU, Shuangying SHAKESPEARE, William, C. THOMAS, R., Mathew QI, Jiwei LI, Feng ZHU, Xiaotian KOHLMANN, Anna DALGARNO, David, C. ROMERO, Jan, Antoinette, C. ZOU, Dong |
||||||||||||||||||||
| Current Proprietor |
TAKEDA PHARMACEUTICAL COMPANY LIMITED 1-1, Doshomachi 4-chome Chuo-ku Osaka-shi Osaka JAPAN |
||||||||||||||||||||
| Address for service |
Valipat Avenue Louise 54 1050 Brussels BELGIUM |
||||||||||||||||||||
| Renewal Fees |
|
||||||||||||||||||||
| Publication Language | English | ||||||||||||||||||||
| Translation Received Date | |||||||||||||||||||||
| 07/09/2017 | Divisional Application number: 17162419.0 Date of receipt: 22/03/2017 | ||||||||||||||||||||
| 29/11/2017 | Change of address of proprietor from ARIAD PHARMACEUTICALS, INC., 125 Binney Street, Cambridge, MA 02142, United States of America to ARIAD PHARMACEUTICALS, INC., 40 Landsdowne Street, Cambridge, MA 02139, United States of America recorded on 21/11/2017. | ||||||||||||||||||||
| 04/12/2017 | Address for Service recorded as VALIPAT S.A., Rue de Livourne, 7, B-1060 BRUSSELS, Belgium received on 21/11/2017. | ||||||||||||||||||||
| 28/05/2019 | Request for grant a Supplementary Protection Certificate, citing Patent number 2300013 as the relevant basic patent, in respect of the product Brigatinib, or a pharmaceutically acceptable salt thereof. filed on 17/05/2019. Reference number of request is 2019/031. | ||||||||||||||||||||
| 22/04/2020 | Supplementary Protection Certificate Number 2019/031, having an expiry date of 25/11/2033 granted on 22/04/2020. | ||||||||||||||||||||
| 15/07/2021 | Change of Proprietorship from ARIAD PHARMACEUTICALS, INC., 40 Landsdowne Street, Cambridge, MA 02139, United States of America to TAKEDA PHARMACEUTICAL COMPANY LIMITED, 1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shi, Osaka, Japan, by virtue of Deed of Assignment, dated 03/05/2021. | ||||||||||||||||||||
| 30/08/2021 | Change of Address for Service from VALIPAT S.A., Rue de Livourne, 7, B-1060 BRUSSELS, Belgium to VALIPAT S.R.L., Uitbreidingstraat 72 - 5, 2600 Antwerp, Belgium recorded on 18/08/2021 | ||||||||||||||||||||
| 18/10/2024 | Change of Address for Service from VALIPAT S.R.L., Uitbreidingstraat 72 - 5, 2600 Antwerp, Belgium to Valipat, Avenue Louise 54, 1050 Brussels, Belgium recorded on 16/10/2024 | ||||||||||||||||||||
| 14/11/2024 | Amendment of patent specification as a result of opposition proceedings at the EPO on 13/11/2024 | ||||||||||||||||||||
